{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T11:21:26Z","timestamp":1778498486460,"version":"3.51.4"},"reference-count":40,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100012353","name":"Deutschen Konsortium f\u00fcr Translationale Krebsforschung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012353","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012353","name":"Deutschen Konsortium f\u00fcr Translationale Krebsforschung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012353","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","pathologyjournal.rcpa.edu.au","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.pathol.2019.01.010","type":"journal-article","created":{"date-parts":[[2019,4,19]],"date-time":"2019-04-19T20:34:19Z","timestamp":1555706059000},"page":"362-368","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Several genotypes, one phenotype: PIK3CA\/AKT1 mutation-negative hidradenoma papilliferum show genetic lesions in other components of the signalling network"],"prefix":"10.1016","volume":"51","author":[{"given":"Nicole","family":"Pfarr","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Allg\u00e4uer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7269-5433","authenticated-orcid":false,"given":"Katja","family":"Steiger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wilko","family":"Weichert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Schirmacher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aurelia","family":"Noske","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Albrecht","family":"Stenzinger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pathol.2019.01.010_bib1","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1097\/DAD.0000000000000495","article-title":"Hidradenoma papilliferum: a clinicopathologic study of 264 tumors from 261 patients, with emphasis on mammary-type alterations","volume":"38","author":"Konstantinova","year":"2016","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.pathol.2019.01.010_bib2","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1002\/gcc.22315","article-title":"Mutations in genes encoding PI3K-AKT and MAPK signaling define anogenital papillary hidradenoma","volume":"55","author":"Pfarr","year":"2016","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.pathol.2019.01.010_bib3","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.humpath.2016.04.014","article-title":"Frequent PIK3CA-activating mutations in hidradenoma papilliferums","volume":"55","author":"Liau","year":"2016","journal-title":"Hum Pathol"},{"key":"10.1016\/j.pathol.2019.01.010_bib4","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1136\/jclinpath-2016-204003","article-title":"PIK3CA and AKT1 mutations in hidradenoma papilliferum","volume":"70","author":"Goto","year":"2017","journal-title":"J\u00a0Clin Pathol"},{"key":"10.1016\/j.pathol.2019.01.010_bib5","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.anndiagpath.2017.02.004","article-title":"Molecular alterations in lesions of anogenital mammary-like glands and their mammary counterparts including hidradenoma papilliferum, intraductal papilloma, fibroadenoma and phyllodes tumor","volume":"28","author":"Konstantinova","year":"2017","journal-title":"Ann Diagn Pathol"},{"key":"10.1016\/j.pathol.2019.01.010_bib6","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.humpath.2016.09.034","article-title":"Mutations of cancer-related genes in benign tumors: the example of hidradenoma papilliferum","volume":"62","author":"Pfarr","year":"2017","journal-title":"Hum Pathol"},{"key":"10.1016\/j.pathol.2019.01.010_bib7","series-title":"WHO Classification of Tumours of Female Reproductive Organs","author":"Kurman","year":"2014"},{"key":"10.1016\/j.pathol.2019.01.010_bib8","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.jmoldx.2013.06.002","article-title":"Molecular diagnostic profiling of lung cancer specimens with a semiconductor-based massive parallel sequencing approach: feasibility, costs, and performance compared with conventional sequencing","volume":"15","author":"Endris","year":"2013","journal-title":"J\u00a0Mol Diagn"},{"key":"10.1016\/j.pathol.2019.01.010_bib9","doi-asserted-by":"crossref","first-page":"3176","DOI":"10.1128\/JCM.42.7.3176-3184.2004","article-title":"Detection and typing of human papillomavirus by e6 nested multiplex PCR","volume":"42","author":"Sotlar","year":"2004","journal-title":"J\u00a0Clin Microbiol"},{"key":"10.1016\/j.pathol.2019.01.010_bib10","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1002\/gcc.22480","article-title":"Mutational profiles of Brenner tumors show distinctive features uncoupling urothelial carcinomas and ovarian carcinoma with transitional cell histology","volume":"56","author":"Pfarr","year":"2017","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.pathol.2019.01.010_bib11","doi-asserted-by":"crossref","first-page":"e164","DOI":"10.1093\/nar\/gkq603","article-title":"ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data","volume":"38","author":"Wang","year":"2010","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.pathol.2019.01.010_bib12","doi-asserted-by":"crossref","first-page":"D805","DOI":"10.1093\/nar\/gku1075","article-title":"COSMIC: exploring the world's knowledge of somatic mutations in human cancer","volume":"43","author":"Forbes","year":"2015","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.pathol.2019.01.010_bib13","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1158\/1078-0432.CCR-10-0540","article-title":"A\u00a0unique spectrum of somatic PIK3CA (p110alpha) mutations within primary endometrial carcinomas","volume":"17","author":"Rudd","year":"2011","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.pathol.2019.01.010_bib14","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1158\/1078-0432.CCR-17-2141","article-title":"PIK3CA C2 domain deletions hyperactivate phosphoinositide 3-kinase (PI3K), generate oncogene dependence, and are exquisitely sensitive to PI3Kalpha inhibitors","volume":"24","author":"Croessmann","year":"2018","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.pathol.2019.01.010_bib15","first-page":"7426","article-title":"The phosphatidylinositol 3'-kinase p85alpha gene is an oncogene in human ovarian and colon tumors","volume":"61","author":"Philp","year":"2001","journal-title":"Cancer Res"},{"key":"10.1016\/j.pathol.2019.01.010_bib16","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1126\/science.1150799","article-title":"The structure of a human p110alpha\/p85alpha complex elucidates the effects of oncogenic PI3Kalpha mutations","volume":"318","author":"Huang","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.pathol.2019.01.010_bib17","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.ccr.2009.10.016","article-title":"Somatic mutations in p85alpha promote tumorigenesis through class IA PI3K activation","volume":"16","author":"Jaiswal","year":"2009","journal-title":"Cancer Cell"},{"key":"10.1016\/j.pathol.2019.01.010_bib18","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1126\/science.1135394","article-title":"Mechanism of two classes of cancer mutations in the phosphoinositide 3-kinase catalytic subunit","volume":"317","author":"Miled","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.pathol.2019.01.010_bib19","doi-asserted-by":"crossref","first-page":"297","DOI":"10.2217\/pgs.15.174","article-title":"Targeting therapeutic liabilities engendered by PIK3R1 mutations for cancer treatment","volume":"17","author":"Cheung","year":"2016","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.pathol.2019.01.010_bib20","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1097\/01.cco.0000198021.99347.b9","article-title":"Oncogenic PI3K and its role in cancer","volume":"18","author":"Samuels","year":"2006","journal-title":"Curr Opin Oncol"},{"key":"10.1016\/j.pathol.2019.01.010_bib21","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/nature12113","article-title":"Integrated genomic characterization of endometrial carcinoma","volume":"497","author":"Kandoth","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.pathol.2019.01.010_bib22","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/nature19057","article-title":"Analysis of protein-coding genetic variation in 60,706 humans","volume":"536","author":"Lek","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.pathol.2019.01.010_bib23","doi-asserted-by":"crossref","first-page":"D862","DOI":"10.1093\/nar\/gkv1222","article-title":"ClinVar: public archive of interpretations of clinically relevant variants","volume":"44","author":"Landrum","year":"2016","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.pathol.2019.01.010_bib24","article-title":"OncoKB: a precision oncology knowledge base","volume":"2017","author":"Chakravarty","year":"2017","journal-title":"JCO Precis Oncol"},{"key":"10.1016\/j.pathol.2019.01.010_bib25","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1046\/j.1365-2443.2000.00385.x","article-title":"Membrane-associated guanylate kinase with inverted orientation (MAGI)-1\/brain angiogenesis inhibitor 1-associated protein (BAP1) as a scaffolding molecule for Rap small G protein GDP\/GTP exchange protein at tight junctions","volume":"5","author":"Mino","year":"2000","journal-title":"Genes Cells"},{"key":"10.1016\/j.pathol.2019.01.010_bib26","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/onc.2011.218","article-title":"Identification of MAGI1 as a tumor-suppressor protein induced by cyclooxygenase-2 inhibitors in colorectal cancer cells","volume":"31","author":"Zaric","year":"2012","journal-title":"Oncogene"},{"key":"10.1016\/j.pathol.2019.01.010_bib27","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s12185-017-2359-1","article-title":"MAGI-1 expression is decreased in several types of human T-cell leukemia cell lines, including adult T-cell leukemia","volume":"107","author":"Kozakai","year":"2018","journal-title":"Int J Hematol"},{"key":"10.1016\/j.pathol.2019.01.010_bib28","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1126\/science.8272873","article-title":"Association and activation of Jak-Tyk kinases by CNTF-LIF-OSM-IL-6 beta receptor components","volume":"263","author":"Stahl","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.pathol.2019.01.010_bib29","doi-asserted-by":"crossref","first-page":"3041","DOI":"10.1002\/eji.1830251109","article-title":"Interleukin-7 can induce the activation of Jak 1, Jak 3 and STAT 5 proteins in murine T cells","volume":"25","author":"Foxwell","year":"1995","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.pathol.2019.01.010_bib30","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1128\/MCB.01220-13","article-title":"Stat5 regulates the phosphatidylinositol 3-kinase\/Akt1 pathway during mammary gland development and tumorigenesis","volume":"34","author":"Schmidt","year":"2014","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.pathol.2019.01.010_bib31","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1038\/nature09208","article-title":"Diverse somatic mutation patterns and pathway alterations in human cancers","volume":"466","author":"Kan","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.pathol.2019.01.010_bib32","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","article-title":"The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data","volume":"2","author":"Cerami","year":"2012","journal-title":"Cancer Discov"},{"key":"10.1016\/j.pathol.2019.01.010_bib33","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.ceb.2014.01.005","article-title":"Novel insights into G protein and G protein-coupled receptor signaling in cancer","volume":"27","author":"O'Hayre","year":"2014","journal-title":"Curr Opin Cell Biol"},{"key":"10.1016\/j.pathol.2019.01.010_bib34","doi-asserted-by":"crossref","first-page":"213","DOI":"10.3109\/15419061.2013.855727","article-title":"Adhesion G-protein-coupled receptors: elusive hybrids come of age","volume":"20","author":"Simundza","year":"2013","journal-title":"Cell Commun Adhes"},{"key":"10.1016\/j.pathol.2019.01.010_bib35","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1186\/s13059-014-0484-1","article-title":"Benchmarking mutation effect prediction algorithms using functionally validated cancer-related missense mutations","volume":"15","author":"Martelotto","year":"2014","journal-title":"Genome Biol"},{"key":"10.1016\/j.pathol.2019.01.010_bib36","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1097\/PAS.0000000000001080","article-title":"Intraductal papillary mucinous neoplasms of minor salivary glands with AKT1\u00a0p.Glu17Lys mutation","volume":"42","author":"Agaimy","year":"2018","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.pathol.2019.01.010_bib37","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/nrc3845","article-title":"Shouldn't we care about the biology of benign tumours?","volume":"14","author":"Marino-Enriquez","year":"2014","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.pathol.2019.01.010_bib38","doi-asserted-by":"crossref","first-page":"570","DOI":"10.18632\/oncotarget.2677","article-title":"The landscape of metastatic progression patterns across major human cancers","volume":"6","author":"Budczies","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.pathol.2019.01.010_bib39","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.cell.2018.03.035","article-title":"Oncogenic Signaling Pathways in The Cancer Genome Atlas","volume":"173","author":"Sanchez-Vega","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.pathol.2019.01.010_bib40","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1038\/gim.2017.241","article-title":"Clinical whole-genome sequencing from routine formalin-fixed, paraffin-embedded specimens: pilot study for the 100,000 Genomes Project","volume":"20","author":"Robbe","year":"2018","journal-title":"Genet Med"}],"container-title":["Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031302518303519?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031302518303519?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,4,5]],"date-time":"2021-04-05T15:01:57Z","timestamp":1617634917000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0031302518303519"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":40,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["S0031302518303519"],"URL":"https:\/\/doi.org\/10.1016\/j.pathol.2019.01.010","relation":{},"ISSN":["0031-3025"],"issn-type":[{"value":"0031-3025","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Several genotypes, one phenotype: PIK3CA\/AKT1 mutation-negative hidradenoma papilliferum show genetic lesions in other components of the signalling network","name":"articletitle","label":"Article Title"},{"value":"Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pathol.2019.01.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Royal College of Pathologists of Australasia. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}